about
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipientsTGF-β1/Smads and miR-21 in Renal Fibrosis and InflammationUrinary exosome miRNome analysis and its applications to salt sensitivity of blood pressureBiases in small RNA deep sequencing data.miRNAs as biomarkers for diagnosis of heart failure: A systematic review and meta-analysis.Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsiesCharacterization of human plasma-derived exosomal RNAs by deep sequencing.Differential inflammatory microRNA and cytokine expression in pulmonary sarcoidosis.Signaling by exosomal microRNAs in cancer.miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan.Exosomal miRNAs: Biological Properties and Therapeutic Potential.Extracellular membrane vesicles and immune regulation in the brain.Microvesicles/exosomes as potential novel biomarkers of metabolic diseasesUrine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.Targeting nrf2-mediated gene transcription by triterpenoids and their derivatives.Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarctionMicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.Circulating microRNAs as Potential Biomarkers of Infectious Disease.Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.MicroRNAs in cancer diagnosis and therapy: from bench to bedside.Circulating miRNA profiling to identify biomarkers of dysmetabolism.Circulating microRNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke.Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells.Low Levels of MicroRNA-21 Are a Marker of Reduced Arterial Stiffness in Well-Controlled Hypertension.MicroRNAs and Alzheimer's Disease Mouse Models: Current Insights and Future Research Avenues.Identification and Evaluation of Novel MicroRNA Biomarkers in Plasma and Feces Associated with Drug-induced Intestinal Toxicity.Circulating MicroRNAs As Potential Biomarkers for Veterinary Infectious Diseases.Seminal plasma microRNAs: potential biomarkers for spermatogenesis status.Stability of serum high-density lipoprotein-microRNAs for preanalytical conditions.Noncoding RNA: The Major Output of Gene Expression
P2860
Q27312010-8B8AE941-8C42-4CD9-A3D5-23D60E583C31Q28067425-6CAA75F1-A968-4314-8CBD-0DF209D69C12Q30417075-7DC6C9E0-D173-46E7-9DA9-18735F0E83E8Q30689935-7CA6D0D1-D5BA-4A81-AFDA-D108BF56FB81Q33765415-BC64010D-C978-4D37-8CDD-A26DE54B4686Q34461828-89D94775-B030-423B-BF1C-9036E102ABC9Q34467266-433FBE3F-675C-4E05-9F2D-C1B0F2C660DFQ34714581-34C95C38-2736-4C62-9D74-6FAF69E665EDQ35176239-21906068-AB1B-459A-9B87-BEC774861125Q35344075-258235A5-FBDA-48D9-85D5-FB6E6649AC30Q35819563-BC9F59CB-BCDE-4803-B0EE-02A6A4ECE249Q35899396-5DE7D3E7-2DB5-4FAC-AF9A-705BC678619DQ35924477-B88E61EA-8B71-4B79-816D-57C5965505D6Q36175435-5BD3450F-7FBA-4AA6-83ED-ADCC4D7F357EQ36997188-1279A28A-9603-4850-9B63-EF83F23E79BEQ37145435-C7F875FA-D639-4C1E-B4B9-3BA0DC1A7C65Q37516362-6C7BF318-0944-4932-84C3-7CED0B766B0FQ37565264-98C79A64-9F46-432F-AD4D-307574E3EEA5Q37632129-E9F4A125-4581-4333-8945-F73DAED74D28Q37643903-E8D3EC3F-9B85-41F7-9C42-6AA35C0282F4Q37653706-C9D3AD96-55C7-4013-B091-C9B3C1A50D85Q38057979-2F953683-258E-417D-97D2-4CC6F8275504Q38066239-6A841254-64AC-45AF-868E-AE3E0AEEE616Q38153192-D22DD80F-B211-4F9A-A634-6307F45B2A61Q38699403-00C5B8DD-DC69-4F61-949F-FF69B2C30C65Q38828855-BC2B3550-9723-4AD8-855D-828EDEA2CE0CQ39719620-644BBCE5-116B-443D-949D-AC68CB96DA7BQ46155121-4A79811E-3BE5-4BA9-B580-F87B712CDAA8Q47151532-BCD02347-211C-4109-AE7E-9DBEF21A07F6Q47654495-B057D3BE-4B28-4841-B69C-5DD999DEAB0EQ53102316-891C6C77-842B-4B77-9D62-8BD382863DAAQ58883615-2A1E6C06-0DBC-4AD1-8DB3-D444DB462907
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs as biomarkers of disease onset.
@en
MicroRNAs as biomarkers of disease onset.
@nl
type
label
MicroRNAs as biomarkers of disease onset.
@en
MicroRNAs as biomarkers of disease onset.
@nl
prefLabel
MicroRNAs as biomarkers of disease onset.
@en
MicroRNAs as biomarkers of disease onset.
@nl
P2093
P2860
P1476
MicroRNAs as biomarkers of disease onset
@en
P2093
Agnieszka Loboda
Alicja Jozkowicz
Jozef Dulak
Magdalena Kozakowska
P2860
P2888
P304
P356
10.1007/S00216-011-5001-8
P407
P577
2011-05-06T00:00:00Z